Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIconic Labs Regulatory News (ICON)

Share Price Information for Iconic Labs (ICON)

Share Price is delayed by 15 minutes
Get Live Data
1.70    0.00 (0.00%)
Bid:
1.55
Ask:
1.85
Spread: 0.30 (19.355%)
Market Cap: £264.88k
ICON Live PriceLast checked at - London Stock Exchange

Intraday Iconic Labs Share Chart

Directorate Change

30 Dec 2019 07:00

RNS Number : 1819Y
Iconic Labs PLC
30 December 2019
 

30 December 2019

Iconic Labs Plc ("Iconic Labs" or the "Company")

Board Changes

 

Iconic Labs Plc (LSE:ICON), a multi-divisional new media and technology business, announces that it has been informed by the Chairman, David Sefton, that he wishes to resign from the board at the conclusion of the AGM, which is to be held later today.

 

David explained to the Company that while he will continue to be involved in and support the Company's operations, and in particular business development, he felt that rumour and market speculation in respect of one of his previous companies, Anglo African Oil & Gas Plc ("AAOG"), was having an adverse effect on the Company such that it was in the interest of the Company that he is not involved as a director or in the financing plans for the Company at this time.

 

David resigned as Chairman of AAOG earlier this year, at which time it was planning to increase production and cashflow by drilling a sidetrack before the end of 2019 and capital had been raised for that purpose. David has had no involvement with AAOG since then. David explained that he is therefore not privy to any exact details of the issues that have arisen there since he left, but has every confidence in the board of AAOG to resolve them as best they can in the interests of the shareholders and in order to realise value from the Tilapia asset.

The board is very grateful that David will continue to be involved with the Company but understands his reluctance to continue as a director at this time. As a result, John Quinlan will assume the role of interim chairman. As previously announced, the board recognises the benefit of experienced non-executive directors with the right sector and corporate skills to best help the Company as it accelerates its growth. In this regard, discussions are underway and the Company will make announcements in due course.

 

Resolution 4 will therefore not be put forward for consideration at the AGM to be held later today. The result of the other resolutions will be announced at the completion of the meeting.

 

Market Abuse Regulation (MAR) Disclosure - Certain information contained in this announcement would have been deemed inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 until the release of this announcement.

 

**ENDS**

 

For further information, please visit the Company's website www.iconiclabs.co.uk or contact:

 

John Quinlan

Iconic Labs Plc

c/o SBP Tel: +44 (0) 20 7236 1177

Damon Heath

Shard Capital Partners LLP

Tel: +44 (0) 20 7186 9950

Erik Woolgar

Shard Capital Partners LLP

Tel: +44 (0) 20 7186 9950

Hugo de Salis

St Brides Partners Limited

Tel: +44 (0) 20 7236 1177

David Penson

St Brides Partners Limited

Tel: +44 (0) 20 7236 1177

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAFEMFWUFUSESE
Date   Source Headline
2nd Jun 20265:18 pmRNSConversion of Notes and Allotment of Shares
29th May 20267:00 amRNSTotal Voting Rights
29th Apr 202612:58 pmRNSConversion of Notes and Allotment of Shares
31st Mar 20267:00 amRNSInterim Results
27th Feb 202610:23 amRNSTotal Voting Rights
23rd Feb 20267:00 amRNSConversion of Notes and Allotment of Shares
31st Dec 202511:37 amRNSResult of AGM
8th Dec 20252:16 pmRNSNotice of AGM
23rd Oct 20252:30 pmRNSFull Year Results
12th Aug 20252:04 pmRNSUpdate on Compliance with UK Listing Rules
30th Jun 20253:27 pmRNSHolding(s) in Company
30th Jun 20253:25 pmRNSHolding(s) in Company
30th Jun 20257:00 amRNSTotal Voting Rights
9th Jun 20254:28 pmRNSConversion of Notes and Allotment of Shares
6th Jun 20259:48 amRNSConversion of Notes and Allotment of Shares
3rd Jun 20252:54 pmRNSConversion of Notes and Allotment of Shares
30th May 20254:00 pmRNSConversion of Notes and Allotment of Shares
28th May 20255:24 pmRNSConversion of Notes and Allotment of Shares
28th May 20254:54 pmRNSHolding(s) in Company
28th May 20254:52 pmRNSHolding(s) in Company
28th May 20254:50 pmRNSHolding(s) in Company
28th May 20254:48 pmRNSHolding(s) in Company
20th May 20257:30 amRNSRestoration Iconic Labs Plc
20th May 20257:00 amRNSRestoration of Trading and Funding Update
15th May 20254:18 pmRNSResult of AGM
24th Apr 20255:16 pmRNSNotice of AGM
31st Mar 20256:41 pmRNSInterim Results
31st Mar 20255:26 pmRNSRevised Results for the Year ended 30 June 2024
13th Feb 20255:55 pmRNSTransaction Terminated
7th Feb 20252:52 pmRNSNotification of Major Holdings
31st Oct 20243:57 pmRNSFull Year Results for the Year ended 30 June 2024
9th Sep 20247:00 amRNSWaiver of Event of Default
10th Jul 20244:22 pmRNSBoard Changes
28th Mar 20247:00 amRNSInterim Results
11th Mar 202412:00 pmRNSHeads of Terms Signed
29th Feb 20247:00 amRNSTotal Voting Rights
29th Feb 20247:00 amRNSSuspension of Trading
13th Feb 20242:08 pmRNSResult of AGM
7th Feb 20249:10 amRNSConversion of Notes and Allotment of Shares
19th Jan 20243:49 pmRNSNotice of AGM
4th Jan 20247:00 amRNSBoard Changes & Business and Strategy Update
29th Dec 20237:00 amRNSTotal Voting Rights
7th Dec 20238:53 amRNSConversion of Securities
4th Dec 20237:53 amRNSConversion of Securities
30th Nov 20237:00 amRNSTotal Voting Rights
17th Nov 202311:32 amRNSConversion of Securities
13th Nov 20238:40 amRNSConversion of Securities
2nd Nov 202310:35 amRNSConversion of Securities
31st Oct 20239:29 amRNSTotal Voting Rights
31st Oct 20237:00 amRNSFull Year Results for the Year ended 30 June 2023

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.